Organisation paid for research Program year 2025 Source: CMS Open Payments

Carolina Eyecare Physicians LLC

Neither a doctor nor a teaching hospital

Research payments

$1,603,080

846 payments

Through program year 2025, Carolina Eyecare Physicians LLC is reported as receiving $1,603,080 in research payments, across 846 payments.

By program year

7 rows
Year Kind Amount Payments
2025 Research $165,018 36
2024 Research $295,282 305
2023 Research $610,555 319
2022 Research $124,591 10
2021 Research $143,078 152
2020 Research $189,214 7
2019 Research $75,341 17

Breakdown

Who paid Research payments · program years 2019–2025
  1. Alcon Research LLC $1,229,022 726 payments
  2. Genentech, Inc. $181,229 16 payments
  3. RxSight Inc $161,462 101 payments
  4. Roche TCRC, Inc. $28,367 2 payments
  5. Oyster Point Pharma, Inc. $3,000 1 payment
Studies the money was for Research payments · program years 2019–2025
  1. Clareon Toric vs Eyhance Toric $467,047 282 payments
  2. Contralateral Study of Clareon PanOptix Pro vs. Clareon PanOptix $231,158 238 payments
  3. Study of the Port Delivery System With Ranibizumab in Patients With Diabetic MacUlar Edema $158,674 15 payments
  4. Pivotal Trial of WaveLight EX500 Excimer Laser System for the Correction of Myopia with and without Astigmatism Using InnovEyes in Conjunction with InnovEyes sightmap $156,114 158 payments
  5. Visual Outcomes, Patient Satisfaction and Spectacle Independence Evaluation of the Acrysof IQ Vivity Intraocular Lens Targeted for Nanovision $116,891 2 payments
  6. Evaluation of Intraocular Lens Calculation Formulas and Angle Kappa in Acrysof IQ Panoptix Intraocular Lens Outcomes and Patient Satisfaction $98,745 2 payments
  7. RxSight Light Adjustable Lens and Light Delivery Device New Enrollment Study $90,850 12 payments
  8. RxSight Light Adjustable Lens and Light Delivery Device New Enrollment Study $66,612 87 payments
  9. PMCF Evaluation of Clareon Vivity and Vivity Toric $44,624 23 payments
  10. Visual Outcomes, Patient Satisfaction and Spectacle Independence Evaluation of the Acrysof IQ Vivity Intraocular Lens Targeted for Emmetropia or Nano-vision. $34,518 1 payment

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record